Agenus, Inc. (AGEN)
7.67
-0.42
(-5.19%)
USD |
NASDAQ |
Aug 24, 16:00
7.67
0.00 (0.00%)
After-Hours: 20:00
Agenus Debt to Equity Ratio : -1.458 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.458 |
| March 31, 2026 | -1.376 |
| December 31, 2025 | -1.235 |
| September 30, 2025 | -1.244 |
| June 30, 2025 | -1.136 |
| March 31, 2025 | -1.220 |
| December 31, 2024 | -1.322 |
| September 30, 2024 | -1.439 |
| June 30, 2024 | -1.706 |
| March 31, 2024 | -1.726 |
| December 31, 2023 | -2.184 |
| September 30, 2023 | -2.746 |
| June 30, 2023 | -3.801 |
| March 31, 2023 | -6.101 |
| December 31, 2022 | -6.037 |
| September 30, 2022 | -17.19 |
| June 30, 2022 | 100.90 |
| March 31, 2022 | 20.06 |
| December 31, 2021 | 9.079 |
| September 30, 2021 | 7.347 |
| June 30, 2021 | -1.338 |
| March 31, 2021 | -1.786 |
| December 31, 2020 | -1.642 |
| September 30, 2020 | -1.592 |
| June 30, 2020 | -1.392 |
| Date | Value |
|---|---|
| March 31, 2020 | -1.496 |
| December 31, 2019 | -1.234 |
| September 30, 2019 | -1.353 |
| June 30, 2019 | -1.797 |
| March 31, 2019 | -2.806 |
| December 31, 2018 | -0.1043 |
| September 30, 2018 | -0.1054 |
| June 30, 2018 | -0.1219 |
| March 31, 2018 | -0.1188 |
| December 31, 2017 | -1.673 |
| September 30, 2017 | -2.168 |
| June 30, 2017 | -6.394 |
| March 31, 2017 | 12.54 |
| December 31, 2016 | -2.866 |
| September 30, 2016 | -5.320 |
| June 30, 2016 | 7.304 |
| March 31, 2016 | 2.661 |
| December 31, 2015 | 1.618 |
| September 30, 2015 | 1.438 |
| June 30, 2015 | 0.1311 |
| March 31, 2015 | 0.2487 |
| December 31, 2014 | 0.2618 |
| September 30, 2014 | 0.1374 |
| June 30, 2014 | 0.1289 |
| March 31, 2014 | 0.1479 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Iovance Biotherapeutics, Inc. | 0.0625 |
| Novavax, Inc. | -1.559 |
| Fate Therapeutics, Inc. | 0.4932 |
| Amgen, Inc. | 4.903 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 172.69M |
| Total Liabilities (Quarterly) | 378.54M |
| Shareholders Equity (Quarterly) | -199.08M |
| Current Ratio | 0.34 |
| Net Debt Paydown Yield | 19.44% |